Antimicrobial Resistance and Mortality in Hospitalized Patients with Bacteremia in the Greater Paris Area from 2016 to 2019.

"Disclosure Funding received by SA had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results. LW received consulting fees from Pfizer, HEVA, IQVIA for unrelated projects. Other authors report no competing interests. The authors report no other conflicts of interest in this work."

"Doctoral fellowship was received by SA from the Ecole des Hautes Etudes en Santé Publique (EHESP, https://www.ehesp.fr/)."

"Ethics Approval: This observational study uses routinely collected data. This study received approval from the Scientific and Ethical Committee of the Assistance Publique – Hôpitaux de Paris on March 28, 2019 and is registered on Clinicaltrials.gov (NCT04065750). The AP-HP clinical data warehouse initiative ensures patient information and informed consent regarding the different approved studies in accordance with European Regulation on data protection and authorization n°1980120 from the French Data Protection Authority (Commission Nationale de l’Informatique et des Libertés, CNIL)."